A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
出版年份 2021 全文链接
标题
A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
作者
关键词
-
出版物
Cell Reports
Volume 38, Issue 3, Pages 110256
出版商
Elsevier BV
发表日期
2021-12-23
DOI
10.1016/j.celrep.2021.110256
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
- (2021) Philip J.M. Brouwer et al. CELL
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- (2021) Summer E. Galloway et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
- (2021) Abigail E. Powell et al. ACS Central Science
- No higher infectivity but immune escape of SARS-CoV-2 501Y.V2 variants
- (2021) Qianqian Li et al. CELL
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- The Variant Gambit: COVID’s Next Move
- (2021) Jessica A. Plante et al. Cell Host & Microbe
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
- (2021) Allison J. Greaney et al. Cell Host & Microbe
- Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
- (2021) Rong Li et al. Cellular & Molecular Immunology
- Emergence of a Novel SARS-CoV-2 Variant in Southern California
- (2021) Wenjuan Zhang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
- (2021) Qingrui Huang et al. Nature Communications
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- The challenge of emerging SARS-CoV-2 mutants to vaccine development
- (2021) Rong Li et al. Journal of Genetics and Genomics
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
- (2021) Prabhu S. Arunachalam et al. NATURE
- ‘Unprecedented achievement’: who received the first billion COVID vaccinations?
- (2021) Freda Kreier NATURE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
- (2021) Xiaoying Shen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
- (2021) Thandeka Moyo-Gwete et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amino acids and RagD potentiate mTORC1 activation in CD8+ T cells to confer antitumor immunity
- (2021) Yiwen Zhang et al. Journal for ImmunoTherapy of Cancer
- Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles
- (2021) Xiantao Zhang et al. Cellular & Molecular Immunology
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
- (2020) Wenjun Wang et al. Nature Nanotechnology
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies
- (2020) Bingfeng Liu et al. Cellular & Molecular Immunology
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
- (2020) Xiancai Ma et al. IMMUNITY
- A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
- (2020) Yfat Yahalom-Ronen et al. Nature Communications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More